Takeda Pharmaceutical Company Limited SEC filings

In the twelve months since 29 September 2025 Takeda Pharmaceutical Company Limited filed 38 documents with the SEC of the kinds listed here: 36 reports on Form 6-K; 1 annual report (foreign filer) (20-F), 1 conflict minerals report (SD). The latest, filed 14 September 2026: 6-K, no title given to edgar; the filing is linked.

A foreign company listed in the US files a Form 6-K for what it publishes at home: results, share buybacks, directors' dealings, bond issues and notices. The 6-K carries no item numbers, so each is listed under the title the company gave EDGAR, where it gave one; the rest are linked to the filing itself. The annual report is the 20-F (or the 40-F for a Canadian filer). Form 144, 13F and Schedule 13D and 13G have their own pages; a foreign filer files no Form 4.

Source

The company's filing index on EDGAR, read from the SEC's submissions feed.